HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The fate of tumour rests following removal of acoustic neuromas: an MRI Gd-DTPA study.

Abstract
The fate of capsular fragments left attached to vital structures at the time of otherwise total tumour removal was studied in 14 of 21 such patients who underwent acoustic neuroma surgery. Imaging using magnetic resonance Gd-DTPA at post-operative intervals of 6 months-12 years (mean 70 months) showed evidence of persistent tumour in half the patients. None of the patients had developed new symptoms and computed tomography had failed to demonstrate tumour recurrence. Persistence of the tumour was more likely if the residual fragments were not cauterized at the time of operation. Four of the seven persisting tumour rests showed evidence of gradual enlargement. The implications for patient management, particularly if an attempt is made to preserve hearing, are discussed.
AuthorsR H Lye, A Pace-Balzan, R T Ramsden, J E Gillespie, J M Dutton
JournalBritish journal of neurosurgery (Br J Neurosurg) Vol. 6 Issue 3 Pg. 195-201 ( 1992) ISSN: 0268-8697 [Print] England
PMID1632918 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium DTPA
Topics
  • Adult
  • Cerebellum (pathology)
  • Contrast Media
  • Female
  • Follow-Up Studies
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (pathology)
  • Neuroma, Acoustic (pathology, surgery)
  • Organometallic Compounds
  • Pentetic Acid
  • Postoperative Complications (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: